www.alkemlabs.com Open in urlscan Pro
3.109.179.149  Public Scan

URL: https://www.alkemlabs.com/
Submission Tags: phishing malicious Search All
Submission: On October 17 via api from NL — Scanned from NL

Form analysis 0 forms found in the DOM

Text Content

This website uses cookies to provide you with a personalized browsing
experience. By using this website you agree to our use of cookies as explained
in our Privacy Policy. Please read our Privacy Policy for more information on
how we use cookies and how you can manage them. Privacy Policy
Got it
x

 * Corporate Info
   * About Us
   * Our Values
   * Founders Story
   * Milestones
   * Board of Directors
   * Awards and Recognition
   * Quality
   * Corporate Social Responsibility
 * Global Presence
   * Overview
   * US
   * Australia
   * Europe
     * UK
     * Germany
   * Latin America
     * Chile
     * Colombia
   * Emerging Markets
     * French West Africa
     * South Africa
     * East Africa
     * Philippines
     * Kazakhstan
 * R & D
   * Our Purpose
   * Research Facilities
   * Capabilities
     * Generics
     * Proprietary
     * API
     * Differentiated Products
     * Bioequivalence Center
   * Achievements
 * Manufacturing
   * Manufacturing Facilities
   * Regulatory Accreditation
   * Facility Tour
 * Our Offerings
   * Therapies
     * Anti Infective
     * Anti-Osteoporosis
     * Cardiology
     * CNS
     * Dermatology
     * Diabetology
     * Gastroenterology
     * Gynaecology
     * Oncology
     * Ophthalmology
     * Respiratory
     * Rheumatology
     * Urology
     * Vitamins, Mineral and Nutrition
   * Rx Products
   * Alkem Generics
   * OTC Products
   
   
 * Investor Desk
   * Disclosures under Regulation 46 of LODR
     * Details Of Business
     * Policies
     * Composition of Committees
     * Shareholding Pattern
     * Annual Reports
     * Quarterly Results
     * Notice of Board Meeting
     * Annual Returns
     * Subsidiary Financial Statements
     * Investor/ Analyst Meet
       * Conference Call invite
       * Investor Presentations
       * Earnings Call
       * Schedule of Investor/ Analyst Meet
     * Credit Ratings
     * Familiarization Programme
       * Familiarization Programme Policy
       * Details of Familiarization Programme
     * Contact Details
       * Investor Grievance
       * KMP's for determining materiality
     * Secretarial Compliance Report
     * Newspaper advertisements
     * Disclosure under Regulation 30
       * Outcome of Board Meeting
       * Postal Ballot
       * Annual General Meeting (AGM)
         
       * Other Disclosures
     * Sustainability Report
   * Financial Overview
   * Disclosure on Related Party Transactions
   * Forms
     
   * Dividend Details
   * CSR Action Plan
 * Media Room
   * Press Release
   * News Updates
   * Corporate Press Kit
 * Careers
 * Quick Links
   * Ascend Laboratories
   * Norac Pharma
   * Enzene
 * Contact Us
   * Adverse Event Reporting
   * Partnership
   * Global Locations
   * Key Contacts

To Top
 * 
 * 
 * 


 * Investor Desk
   * Disclosures under Regulation 46 of LODR
     * Details Of Business
       
     * Policies
     * Composition of Committees
     * Shareholding Pattern
     * Annual Reports
     * Quarterly Results
     * Notice of Board Meeting
     * Annual Returns
     * Subsidiary Financial Statements
     * Investor/ Analyst Meet
       * Conference Call invite
       * Investor Presentations
       * Earnings Call
       * Schedule of Investor/ Analyst Meet
     * Credit Ratings
     * Familiarization Programme
       * Familiarization Programme Policy
       * Details of Familiarization Programme
     * Contact Details
       * Investor Grievance
         
       * KMP's for determining materiality
     * Secretarial Compliance Report
     * Newspaper advertisements
     * Disclosure under Regulation 30
       * Outcome of Board Meeting
       * Postal Ballot
       * Annual General Meeting (AGM)
         
       * Other Disclosures
     * Sustainability Report
   * Financial Overview
     
     
     
     
     
   * Disclosure on Related Party Transactions
   * Forms
     
   * Dividend Details
   * CSR Action Plan
 * Media Room
   * Press Release
   * News Updates
   * Corporate Press Kit
 * Careers
 * Quick Links
   * Ascend Laboratories
     * Ascend is US based wholly owned subsidiary of Alkem, provides
       high-quality and cost effective
       generics in several therapeutic areas.
       Click To Visit Web Site
   * Norac Pharma
     * Norac pharma is a preferred
       california-based API contract
       research and manufacturing
       organization.
       Click To visit web site
   * Enzene
     * Enzene is technology driven
       biotechnology company
       based in pune, india.
       Click To Visit Web Site
 * Contact Us
   * Adverse Event Reporting
   * Partnership
   * Global Locations
   * Key Contacts


 * Corporate Info
   * About Us
   * Our Values
   * Founders Story
   * Milestones
   * Board of Directors
   * Awards and Recognition
   * Quality
   * Corporate Social Responsibility
 * Global Presence
   * Overview
   * US
   * Australia
   * Europe
     * UK
     * Germany
   * Latin America
     * Chile
     * Colombia
   * Emerging Markets
     * French West Africa
     * South Africa
     * East Africa
     * Philippines
     * Kazakhstan
 * R & D
   * Our Purpose
   * Research Facilities
   * Capabilities
     * Generics
     * Proprietary
     * API
     * Differentiated Products
     * Bioequivalence Center
   * Achievements
 * Manufacturing
   * Manufacturing Facilities
   * Regulatory Accreditation
   * Facility Tour
 * Our Offerings
   * Therapies
     * Anti Infective
     * Anti-Osteoporosis
     * Cardiology
     * CNS
     * Dermatology
     * Diabetology
     * Gastroenterology
     * Gynaecology
     * Oncology
     * Ophthalmology
     * Respiratory
     * Rheumatology
     * Urology
     * Vitamins, Mineral and Nutrition
   * Rx Products
   * Alkem Generics
   * OTC Products
   
   






FIVE DECADES OF EMPOWERING WELLNESS

With an illustrious journey which stands at striking distance of completing 5
decades, Alkem Laboratories commands the status of one of world's leading global
pharmaceutical formulation development, manufacturing and marketing companies
from India.

Read More



TECHNOLOGICALLY SUPERIOR FOR EMPOWERING HEALTHCARE

A technologically advanced and conducive solution becomes necessary to create
path-breaking innovations in Healthcare. With over 20 facilities, located in
India & USA, Alkem is breaking research barriers everyday


Read More
Help transform the future of healthcare
Help transform the future of healthcare


— Over 21,000 employees. Operational footprints in over 40 countries. 20
facilities and 5 R&D centres. If you are smart, dynamic and hardworking, you are
home at team Alkem. —

Read More



Copyright © Alkem Laboratories Ltd. All Rights Reserved.
Version: 2.1
Privacy Policy | Disclaimer | Sitemap

Best viewed on 1920 x 1080 px, Chrome, Opera, Firefox and Edge